New Orleans Bioinnovation Center Inc
New Orleans Bioinnovation Center Inc. faces persistent operational deficits, drawing down assets over the last decade.
EIN: 200078125 · New Orleans, LA · NTEE: S302 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $2.6M |
| Total Expenses | $3.4M |
| Program Spending | 70% |
| Net Assets | $35.2M |
| Transparency Score | 65/100 |
Is New Orleans Bioinnovation Center Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
New Orleans Bioinnovation Center Inc directs 70% of its spending to programs. This meets the industry benchmark of 65% for efficient nonprofits.
About New Orleans Bioinnovation Center Inc
New Orleans Bioinnovation Center Inc (EIN: 200078125) is a nonprofit organization based in New Orleans, LA, classified under NTEE code S302. The organization reported total revenue of $2.6M and total assets of $34.5M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of New Orleans Bioinnovation Center Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
New Orleans Bioinnovation Center Inc is a mid-size nonprofit that has been operating for 22 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of -16.6%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $2.8M |
| Total Expenses | $3.4M |
| Surplus / Deficit | $-663,819 |
| Total Assets | $36.0M |
| Total Liabilities | $755K |
| Net Assets | $35.2M |
| Operating Margin | -23.9% |
| Debt-to-Asset Ratio | 2.1% |
| Months of Reserves | 125.5 months |
Financial Health Grade: B
In 2023, New Orleans Bioinnovation Center Inc reported a deficit of $664K with expenses exceeding revenue, holds 125.5 months of operating reserves (strong position), has a debt-to-asset ratio of 2.1% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), New Orleans Bioinnovation Center Inc's revenue has declined at a compound annual growth rate (CAGR) of -16.6%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +4.7% | +1.3% | -0.5% |
| 2022 | +2.7% | +8.1% | -2.2% |
| 2021 | +72.5% | +17.8% | -1.3% |
| 2020 | -45.7% | -19.0% | -2.3% |
| 2019 | +84.3% | -2.6% | -4.4% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1200 |
| IRS Ruling Date | 2004 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates New Orleans Bioinnovation Center Inc with a Mission Score of 65 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 20%
- programs: 70%
- fundraising: 10%
According to IRS 990 filings, New Orleans Bioinnovation Center Inc allocates its expenses as follows: admin: 20%, programs: 70%, fundraising: 10%. Approximately 70% goes to programs, indicating moderate mission focus.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $664K, with expenses exceeding revenue.
- Debt-to-asset ratio: 2.1%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, suggesting either a volunteer leadership structure or that executive compensation is not reported in this category, which is unusual for an organization of this size with significant assets and expenses.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of New Orleans Bioinnovation Center Inc's IRS 990 filings:
- Consistent operational deficits: Expenses have exceeded revenue in every reported year from 2014 to 2023.
- Declining asset base: Total assets have decreased from $47,488,986 in 2014 to $35,981,638 in 2023, indicating a draw-down on reserves.
- Unexplained 0% officer compensation: Reporting no officer compensation for an organization with multi-million dollar expenses is highly unusual and may obscure executive remuneration practices.
Strengths
The following positive indicators were identified for New Orleans Bioinnovation Center Inc:
- Substantial asset base: Despite declines, the organization still holds over $35 million in assets, providing a significant financial cushion.
- Consistent filing history: A long history of 13 IRS 990 filings demonstrates a commitment to transparency and regulatory compliance.
- Low liabilities relative to assets: Liabilities remain relatively low compared to total assets, indicating a healthy balance sheet in terms of debt.
Frequently Asked Questions about New Orleans Bioinnovation Center Inc
Is New Orleans Bioinnovation Center Inc a legitimate charity?
New Orleans Bioinnovation Center Inc (EIN: 200078125) is a registered tax-exempt nonprofit based in Louisiana. Our AI analysis gives it a Mission Score of 65/100. It has 13 years of IRS 990 filings on record. Total revenue: $2.6M. 3 red flags identified. 3 strengths noted. Financial health grade: B.
How does New Orleans Bioinnovation Center Inc spend its money?
New Orleans Bioinnovation Center Inc directs 70% of its spending to programs and services. Fundraising costs 10%. This meets the 65% industry benchmark.
Are donations to New Orleans Bioinnovation Center Inc tax-deductible?
New Orleans Bioinnovation Center Inc is registered as a tax-exempt nonprofit (EIN: 200078125). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of New Orleans Bioinnovation Center Inc's spending goes to programs?
New Orleans Bioinnovation Center Inc directs 70% to programs, 10% to fundraising. This meets the 65% industry benchmark for efficient nonprofits.
How does New Orleans Bioinnovation Center Inc compare to similar nonprofits?
With a transparency score of 65/100 (Good), New Orleans Bioinnovation Center Inc is above average for NTEE category S302 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is New Orleans Bioinnovation Center Inc located?
New Orleans Bioinnovation Center Inc is headquartered in New Orleans, Louisiana and files with the IRS under EIN 200078125. It is classified under NTEE code S302.
How many years of IRS 990 filings does New Orleans Bioinnovation Center Inc have?
New Orleans Bioinnovation Center Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $2.6M in total revenue.
What is the detailed breakdown of program, administrative, and fundraising expenses?
The provided data does not offer a detailed breakdown of these expense categories, making it difficult to precisely determine spending efficiency beyond the overall revenue-expense comparison.
How does the organization plan to address its consistent operational deficits?
The filings show a trend of expenses exceeding revenue, leading to a decline in assets. The organization would need to outline strategies for increasing revenue or reducing expenses to achieve financial sustainability.
Why is officer compensation consistently reported as 0%?
This is an unusual finding for an organization with annual expenses exceeding $3 million. It suggests either a volunteer leadership model or that compensation is categorized differently, which warrants further inquiry for full transparency.
What is the specific use of the substantial assets held by the organization?
With assets exceeding $35 million, understanding how these assets are deployed to support the mission, whether in property, investments, or endowments, is crucial for assessing financial health and impact.
Filing History
IRS 990 filing history for New Orleans Bioinnovation Center Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), New Orleans Bioinnovation Center Inc's revenue has declined by 88.6%, moving from $24.4M to $2.8M. Total assets decreased by 17.8% over the same period, from $43.8M to $36.0M. Total functional expenses rose by 273.7%, from $921K to $3.4M. In its most recent filing year (2023), New Orleans Bioinnovation Center Inc reported a deficit of $664K, with expenses exceeding revenue. The organization holds $755K in liabilities against $36.0M in assets (debt-to-asset ratio: 2.1%), resulting in net assets of $35.2M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $2.8M | $3.4M | $36.0M | $755K | — | — |
| 2022 | $2.7M | $3.4M | $36.2M | $640K | — | View 990 |
| 2021 | $2.6M | $3.1M | $37.0M | $723K | — | View 990 |
| 2020 | $1.5M | $2.7M | $37.5M | $668K | — | View 990 |
| 2019 | $2.8M | $3.3M | $38.4M | $363K | — | View 990 |
| 2018 | $1.5M | $3.4M | $40.1M | $1.6M | — | View 990 |
| 2017 | $1.6M | $3.7M | $42.2M | $1.7M | — | View 990 |
| 2016 | $1.6M | $3.8M | $44.5M | $2.1M | — | View 990 |
| 2015 | $2.6M | $3.4M | $46.8M | $2.2M | — | View 990 |
| 2014 | $2.7M | $3.3M | $47.5M | $2.0M | — | View 990 |
| 2013 | $3.6M | $3.7M | $47.9M | $1.8M | — | View 990 |
| 2012 | $8.2M | $1.8M | $47.7M | $1.5M | — | View 990 |
| 2011 | $24.4M | $921K | $43.8M | $4.0M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $2.8M, expenses of $3.4M, and assets of $36.0M (revenue +4.7% year-over-year).
- 2022: Revenue of $2.7M, expenses of $3.4M, and assets of $36.2M (revenue +2.7% year-over-year).
- 2021: Revenue of $2.6M, expenses of $3.1M, and assets of $37.0M (revenue +72.5% year-over-year).
- 2020: Revenue of $1.5M, expenses of $2.7M, and assets of $37.5M (revenue -45.7% year-over-year).
- 2019: Revenue of $2.8M, expenses of $3.3M, and assets of $38.4M (revenue +84.3% year-over-year).
- 2018: Revenue of $1.5M, expenses of $3.4M, and assets of $40.1M (revenue -8.7% year-over-year).
- 2017: Revenue of $1.6M, expenses of $3.7M, and assets of $42.2M (revenue +1.2% year-over-year).
- 2016: Revenue of $1.6M, expenses of $3.8M, and assets of $44.5M (revenue -37.5% year-over-year).
- 2015: Revenue of $2.6M, expenses of $3.4M, and assets of $46.8M (revenue -3.1% year-over-year).
- 2014: Revenue of $2.7M, expenses of $3.3M, and assets of $47.5M (revenue -26.1% year-over-year).
- 2013: Revenue of $3.6M, expenses of $3.7M, and assets of $47.9M (revenue -55.7% year-over-year).
- 2012: Revenue of $8.2M, expenses of $1.8M, and assets of $47.7M (revenue -66.5% year-over-year).
- 2011: Revenue of $24.4M, expenses of $921K, and assets of $43.8M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for New Orleans Bioinnovation Center Inc:
Data Sources and Methodology
This transparency report for New Orleans Bioinnovation Center Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.